Turtle Shell Technologies, the parent company of Dozee, a Bangalore based healthcare startup announced on Tuesday that it received $1.7 Million in funding from Prime Venture Partners, YourNest Venture Capital and 3one4 Capital. Having launched its contactless, vitals monitoring device in 2019, the firm intends to utilize these funds to widen its market outreach, enhance the product’s capabilities & underlying technology and increase its adoption. The company will also focus on completing US FDA & other global certifications and work towards bettering end user experience.

Founded by IIT Bombay alum Mudit Dandwate and IIT Indore alum Gaurav Parchani in 2015, Dozee was designed to enhance chronic disorder management, parent care and critical patient monitoring at home. The device monitors heart rate, respiration rate, oxygen saturation, sleep quality, stress recovery and sleep apnea.

Unlike other popular vital monitoring devices that need to be in contact with the body, Dozee can be placed under the pillow. The device absorbs micro-vibrations produced by heart, respiration and body movements and converts it into biomarkers. Promoting a proactive approach to health monitoring, the device can help in flagging health deterioration early on.

Built around research conducted across major organiztaions such as NIMHANS and Sri Jayadeva Institute, the device boasts of an estimated medical accuracy rate of over 98.4 percent.

Dozee has witnessed an increase in adoption during the ongoing Covid 19 crisis as well. Over 1200 Dozees have been placed across 20 quarantine centers across eight states and has monitored more than 4000 Covid patients in institutional setting. Other than saving precious nursing hours, the device has also enabled hospitals to convert regular beds into step down ICU units owing to the device’s ability to monitor a patient’s cardiac and respiratory cycles.